pipette
ESEspañol

BOP2-ENR: a Bayesian optimal phase II design for adaptive enrichment with family-wise error rate control and a bound on joint-claim power

Kentaro Takeda, Belay B. Yimer, Masahiro Kojima

Preprint

In the authors' words

The Bayesian optimal phase II (BOP2) design accommodates simple and complex endpoints but does not address biomarker-guided enrichment or multiplicity control across pooled and subgroup claims. We propose BOP2-ENR, which monitors biomarker-negative (NG) and biomarker-positive (PG) cohorts separately, permits interim enrichment to PG, and calibrates pooled and PG-restricted claims. Strong family-wise error rate (FWER) control is defined over a prespecified monotone-activity parameter space. Under the mixed configuration in which NG is inactive and PG is active, the probability of a false joint claim is bounded by the probability that NG survives futility monitoring. This exact single-cohort bound does not involve the final efficacy cutoff and also yields a ceiling on joint-claim power. For efficacy-toxicity monitoring, subgroup inactivity is defined by a union null and safety is established separately within each subgroup. Across the scenarios considered and binary, co-primary and efficacy-toxicity endpoints, all selected designs met the prespecified exact-bound and Monte Carlo verification criteria; in sensitivity analyses over odds ratios between component outcomes assumed independent in calibration, point estimates of the error-control quantities remained below the nominal level, although power was association-sensitive. The bound was nearly attained as PG efficacy approached the boundary of the nuisance space, whereas disabling enrichment produced mixed-configuration error rates near one. BOP2-ENR therefore extends the BOP2 framework to adaptive enrichment while clarifying that the NG futility gate governs the mixed-configuration component of strong error control and the attainable power of a joint claim.

Main resultLimitation the authors admit

Appeared: Thursday, October 1. arXiv. Preprint, not yet peer-reviewed.

Authors' comment: 29 pages (manuscript), 18 pages (supporting), 2 figures, and 5 tables